Locations
San Francisco, CA, USA · San Mateo, CA, USA
industry
Biotechnology
Size
11 - 50 employees
Stage
Other
founded in
2019
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases. The company’s first target indication is chronic Hepatitis B, which remains a worldwide prevalent disease with urgent unmet medical need. Bluejay is advancing two innovative approaches with the potential for a high rate of functional cure: best-in-class fully human IgG1 anti-HBs monoclonal antibodies and first-in-class HBsAg oral small molecule inhibitors. The company believes that by reducing Hepatitis B surface antigen and restoring adaptive immunity, a functional cure could be achieved for patients.
Something looks off?On-site & Remote